找回密碼
 To register

QQ登錄

只需一步，快速開始

掃一掃，訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology; Scientific and Clini M. R. Nowrousian Book 20021st edition Springer-Verlag/W

[復(fù)制鏈接]
查看: 27403|回復(fù): 66
樓主
發(fā)表于 2025-3-21 16:28:54 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
副標(biāo)題Scientific and Clini
編輯M. R. Nowrousian
視頻videohttp://file.papertrans.cn/825/824095/824095.mp4
概述Comprehensive presentation of anemia in cancer and its treatment.Assessment of current and potential applications of erythopoietin.Presented by world experts in the field
圖書封面Titlebook: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology; Scientific and Clini M. R. Nowrousian Book 20021st edition Springer-Verlag/W
描述Anemia is a frequent complication of cancer and its treatment. A number of clinical studies shows that the impact of anemia is much greater than previously thought. Beyond clinical symptoms, anemia significantly impairs physical and metabolic functions as well as patients‘ activity, well-being and quality of life. Life expectancy is also affected. In this book, written by a group of outstanding international experts, the current knowledge on anemia in cancer and its treatment with rhEPO is presented and future developments are discussed. Based on a broad spectrum of topics, the book describes the scientific and clinical aspects of anemia in various fields of oncology and gives diagnostic and therapeutic recommendations on when and how to use rhEPO. The book will serve as an authentic and essential source of information for radiotherapists, oncologists, hematologists, internists, pediatricians, surgeons, specialists in transfusion or laboratory medicine and pharmacologists.
出版日期Book 20021st edition
關(guān)鍵詞Fatigue; Tumor; anemia; chemotherapy; classification; hemoglobin; pathophysiology; physiology; radiation onc
版次1
doihttps://doi.org/10.1007/978-3-7091-7658-0
isbn_ebook978-3-7091-7658-0
copyrightSpringer-Verlag/Wien 2002
The information of publication is updating

書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology影響因子(影響力)




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology影響因子(影響力)學(xué)科排名




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology網(wǎng)絡(luò)公開度




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology被引頻次




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology被引頻次學(xué)科排名




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology年度引用




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology年度引用學(xué)科排名




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology讀者反饋




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics
 

0票 0.00%

Better Implies Difficulty
 

1票 100.00%

Good and Satisfactory
 

0票 0.00%

Adverse Performance
 

0票 0.00%

Disdainful Garbage
您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:20:25 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:01:35 | 只看該作者
Yvonne Brandbergth the server-side data portal components:.It is also possible to create your own custom network channel by implementing DataPortalClient.IDataPortalProxy on the client, and Server.IDataPortalServer on the server, just as was done in Chapter 4 to create the four proxy/host combinations listed above.
地板
發(fā)表于 2025-3-22 05:25:28 | 只看該作者
5#
發(fā)表于 2025-3-22 10:33:06 | 只看該作者
Wolfgang Jelkmann M.D.Chapter 9, there are many ways to create a Web Forms interface, and the one I’ve created here is just one option among many..The key is that the business objects automatically enforce all business rules and provide business processing so that the UI doesn’t need to include any of that code. As you c
6#
發(fā)表于 2025-3-22 16:51:18 | 只看該作者
Anders ?sterborgth the server-side data portal components:.It is also possible to create your own custom network channel by implementing DataPortalClient.IDataPortalProxy on the client, and Server.IDataPortalServer on the server, just as was done in Chapter 4 to create the four proxy/host combinations listed above.
7#
發(fā)表于 2025-3-22 17:38:16 | 只看該作者
Mario CazzolaChapter 9, there are many ways to create a Web Forms interface, and the one I’ve created here is just one option among many..The key is that the business objects automatically enforce all business rules and provide business processing so that the UI doesn’t need to include any of that code. As you c
8#
發(fā)表于 2025-3-23 00:21:55 | 只看該作者
M. R. Nowrousianth the server-side data portal components:.It is also possible to create your own custom network channel by implementing DataPortalClient.IDataPortalProxy on the client, and Server.IDataPortalServer on the server, just as was done in Chapter 4 to create the four proxy/host combinations listed above.
9#
發(fā)表于 2025-3-23 04:56:23 | 只看該作者
10#
發(fā)表于 2025-3-23 08:45:52 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 17:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
承德市| 阜康市| 拉萨市| 江达县| 博客| 南阳市| 虞城县| 无锡市| 宿迁市| 定边县| 珠海市| 日土县| 施秉县| 玛沁县| 绿春县| 重庆市| 枣阳市| 高清| 阜南县| 萨嘎县| 绥滨县| 蒙自县| 湛江市| 洛宁县| 镇宁| 阜南县| 安义县| 伽师县| 闸北区| 西充县| 余江县| 开平市| 临湘市| 巩留县| 探索| 镇赉县| 信丰县| 惠安县| 怀化市| 麻江县| 日照市|